{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:05:18Z","timestamp":1760425518834},"reference-count":110,"publisher":"Oxford University Press (OUP)","issue":"suppl_D","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1093\/eurheartj\/sux027","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T10:36:08Z","timestamp":1493807768000},"page":"D102-D112","source":"Crossref","is-referenced-by-count":12,"title":["ANMCO\/ELAS\/SIBioC Consensus Document: biomarkers in heart failure"],"prefix":"10.1093","volume":"19","author":[{"given":"Nadia","family":"Aspromonte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele Massimo","family":"Gulizia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Clerico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Di Tano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Emdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Feola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Iacoviello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Latini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Mortara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Misuraca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Passino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Aimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Ciaccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Migliardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"key":"key\n\t\t\t\t20170725102426_sux027-B1","first-page":"615","article-title":"[ANMCO\/ELAS\/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients]","volume":"17","year":"2016","journal-title":"G Ital Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2014.06.003","article-title":"Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides","volume":"443","year":"2015","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20170725102426_sux027-B3","first-page":"762","article-title":"Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study","volume":"47","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cca.2016.02.017","article-title":"Pilot study on harmonization of cardiac troponin I immunoassays using patients and quality control plasma samples. On behalf of the Italian Section of the European Ligand Assay Society (ELAS) and of the Study Group on Cardiovascular Biomarkers of the Societ\u00e0 Italiana di Biochimica Clinica (SIBioC)","volume":"456","year":"2016","journal-title":"Clin Chem Acta"},{"key":"key\n\t\t\t\t20170725102426_sux027-B5","first-page":"i575","article-title":"Rivaroxaban: can we trust the evidence?","volume":"352","year":"2016","journal-title":"BMJ."},{"key":"key\n\t\t\t\t20170725102426_sux027-B6","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Joint ESC\/ACCF\/AHA\/WHF Task Force for Universal Definition of Myocardial Infarction","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B7","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/eurheartj\/ehs154","article-title":"How to use high-sensitivity cardiac troponins in acute cardiac care","volume":"33","author":"Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102426_sux027-B8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1373\/clinchem.2010.143958","article-title":"Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology\/American College of Cardiology Foundation\/American Heart Association\/World Heart Federation Task Force for the definition of myocardial infarction","volume":"56","year":"2010","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20170725102426_sux027-B9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5858\/2010-0112-OA.1","article-title":"Evaluation of first-draw whole blood, point-of-care cardiac markers in the context of the universal definition of myocardial infarction: a comparison of a multimarker panel to troponin alone and to testing in the central laboratory","volume":"135","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B10","first-page":"99","article-title":"Integrating PoCT into clinical care","volume":"31","year":"2010","journal-title":"Clin Biochem Rev"},{"key":"key\n\t\t\t\t20170725102426_sux027-B11","first-page":"e125","article-title":"Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform","volume":"53","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B12","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1093\/eurheartj\/ehm399","article-title":"Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study","volume":"28","year":"2007","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102426_sux027-B13","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","author":"Authors\/Task Force Members","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102426_sux027-B14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/eurjhf\/hfp035","article-title":"Old and new biomarkers of heart failure","volume":"11","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B15","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1373\/clinchem.2005.064386","article-title":"Rapid brain natriuretic peptide test and Doppler echocardiography for early diagnosis of mild heart failure","volume":"52","year":"2006","journal-title":"Clin Chem."},{"key":"key\n\t\t\t\t20170725102426_sux027-B16","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102426_sux027-B17","first-page":"e1","article-title":"Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline","volume-title":"J Card Fail","author":"Heart Failure Society of America","year":"2010"},{"key":"key\n\t\t\t\t20170725102426_sux027-B18","first-page":"430","article-title":"Recommendations for the clinical use of cardiac natriuretic peptides","volume":"6","author":"Italian Association of Hospital Cardiologists","year":"2005","journal-title":"Ital Heart J"},{"key":"key\n\t\t\t\t20170725102426_sux027-B19","volume-title":"Acute Heart Failure: Diagnosing and Managing Acute Heart Failure in Adults","author":"National Clinical Guideline Centre (UK)","year":"2014"},{"key":"key\n\t\t\t\t20170725102426_sux027-B20","doi-asserted-by":"crossref","first-page":"H12","DOI":"10.1152\/ajpheart.00226.2011","article-title":"Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones","volume":"301","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1373\/clinchem.2007.097998","article-title":"Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage","volume":"54","year":"2008","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20170725102426_sux027-B22","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1373\/clinchem.2011.169151","article-title":"ProBNP1-108 is resistant to degradation and activates Guanylyl Cyclase-A with reduced potency","volume":"57","year":"2011","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20170725102426_sux027-B23","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","article-title":"N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients","volume":"110","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102426_sux027-B24","doi-asserted-by":"crossref","first-page":"70. e23","DOI":"10.1016\/j.amjmed.2005.08.041","article-title":"Incremental prognostic value of changes in B-type natriuretic peptide in heart failure","volume":"119","author":"Val-HeFT Investigators","year":"2006","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B25","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2008.04.069","article-title":"Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)","volume":"52","author":"Val-HeFT Investigators","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/eurheartj\/eht463","article-title":"Natriuretic peptide-guided heart failure management","volume":"35","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102426_sux027-B27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.114.013748","article-title":"Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure","volume":"131","author":"PARADIGM-HF Investigators and Coordinators","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102426_sux027-B28","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170725102426_sux027-B29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s40265-016-0544-9","article-title":"Sacubitril\/Valsartan: a review in chronic heart failure with reduced ejection fraction,","volume":"76","author":"McCormack","year":"2016","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20170725102426_sux027-B30","first-page":"637","article-title":"Neprelysin in heart failure: from oblivion to center stage","volume":"3","year":"2015","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B31","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/archinte.164.18.1978","article-title":"A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure","volume":"164","year":"2004","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B32","first-page":"48","article-title":"Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis","volume":"56","year":"2006","journal-title":"Br J Gen Pract"},{"key":"key\n\t\t\t\t20170725102426_sux027-B33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1373\/clinchem.2006.075713","article-title":"Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of bnp immunoassays in chronic and acute heart failure: a systematic review","volume":"53","year":"2007","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20170725102426_sux027-B34","first-page":"1","article-title":"Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care","volume":"13","year":"2009","journal-title":"Health Technol Assess"},{"key":"key\n\t\t\t\t20170725102426_sux027-B35","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1515\/cclm-2012-0503","article-title":"The diagnostic utility of brain natriuretic peptide in heart failure patients presenting with acute dyspnea: a meta-analysis","volume":"51","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B36","doi-asserted-by":"crossref","first-page":"h910","DOI":"10.1136\/bmj.h910","article-title":"The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting","volume":"350","author":"NICE Guideline Development Group for Acute Heart Failure","year":"2015","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170725102426_sux027-B37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/acem.12878","article-title":"Diagnosing acute heart failure in the emergency department: a systematic review and meta-analysis","volume":"23","year":"2016","journal-title":"Acad Emerg Med."},{"key":"key\n\t\t\t\t20170725102426_sux027-B38","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology","volume":"26","author":"Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology","year":"2005","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102426_sux027-B39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/eurheartj\/ehi044","article-title":"Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology","volume":"26","author":"ESC Committe for Practice Guideline (CPG)","year":"2005","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102426_sux027-B40","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2005.08.022","article-title":"ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)","volume":"46","author":"American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cardfail.2005.12.001","article-title":"Executive summary: HFSA 2006 comprehensive heart failure practice guideline","volume":"12","year":"2006","journal-title":"J Cardiac Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B42","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1373\/clinchem.2006.080234","article-title":"Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure","volume":"53","year":"2007","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20170725102426_sux027-B43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejheart.2004.01.006","article-title":"Natriuretic peptides for risk stratification of patients with acute coronary syndromes","volume":"6","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B44","first-page":"1","article-title":"Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure","volume":"142","year":"2006","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"key\n\t\t\t\t20170725102426_sux027-B45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10741-011-9244-4","article-title":"Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels","volume":"16","year":"2011","journal-title":"Heart Fail Rev"},{"key":"key\n\t\t\t\t20170725102426_sux027-B46","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ahj.2009.06.018","article-title":"Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials","volume":"158","year":"2009","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170725102426_sux027-B47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/archinternmed.2010.35","article-title":"B-type natriuretic peptide-guided heart failure therapy: A meta-analysis","volume":"170","year":"2010","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B48","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-153-11-201012070-00006","article-title":"Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting","volume":"153","year":"2010","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B49","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/CIRCHEARTFAILURE.111.961573","article-title":"Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction","volume":"4","year":"2011","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B50","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/1741826711409171","article-title":"Individual patient meta-analysis of exercise training effects on systemic brain natriuretic peptide expression in heart failure","volume":"19","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B51","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.hlc.2013.03.077","article-title":"B-type natriuretic peptide-guided chronic heart failure therapy: a meta-analysis of 11 randomised controlled trials","volume":"22","year":"2013","journal-title":"Heart Lung Circ"},{"key":"key\n\t\t\t\t20170725102426_sux027-B52","doi-asserted-by":"crossref","first-page":"e58287","DOI":"10.1371\/journal.pone.0058287","article-title":"Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170725102426_sux027-B53","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10741-014-9451-x","article-title":"B-type natriuretic peptide-guided therapy: a systematic review","volume":"19","year":"2014","journal-title":"Heart Fail Rev"},{"key":"key\n\t\t\t\t20170725102426_sux027-B54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jchf.2013.11.007","article-title":"Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis","volume":"2","year":"2014","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2459\/JCM.0b013e328364bde1","article-title":"B-type natriuretic peptide-guided versus symptom-guided therapy in outpatients with chronic heart failure: a systematic review with meta-analysis","volume":"15","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"key\n\t\t\t\t20170725102426_sux027-B56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10741-014-9437-8","article-title":"Does B-type natriuretic peptide-guided therapy improve outcomes in patients with chronic heart failure? A systematic review and meta-analysis of randomized controlled trials","volume":"20","year":"2015","journal-title":"Heart Fail Rev"},{"key":"key\n\t\t\t\t20170725102426_sux027-B57","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/01.CIR.0000054164.99881.00","article-title":"Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)","volume":"107","author":"Val-HeFT Investigators","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102426_sux027-B58","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ahj.2004.07.036","article-title":"Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure","volume":"149","year":"2005","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170725102426_sux027-B59","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","article-title":"Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure","volume":"37","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B60","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/eurheartj\/ehl505","article-title":"Early and sustained effects of cardiac resynchronization therapy on N-terminal pro- B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony","volume":"28","year":"2007","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102426_sux027-B61","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCULATIONAHA.106.655076","article-title":"Prognostic value of very low plasma concentrations of troponin T in patients with stable heart failure","volume":"116","author":"Val-HeFT Investigators","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102426_sux027-B62","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjcard.2012.04.033","article-title":"Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure","volume":"110","year":"2012","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B63","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.amjmed.2014.09.029","article-title":"Prognostic comparison of different sensitivity cardiac troponin assays in stable heart failure","volume":"128","year":"2015","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cca.2013.08.014","article-title":"Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification","volume":"426","year":"2013","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20170725102426_sux027-B65","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/01.CIR.0000084543.79097.34","article-title":"Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure","volume":"108","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102426_sux027-B66","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1373\/clinchem.2013.211706","article-title":"The global need to define normality: the 99th percentile value of cardiac troponin","volume":"60","year":"2014","journal-title":"Clin Chem."},{"key":"key\n\t\t\t\t20170725102426_sux027-B67","article-title":"The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology, and clinical implications","author":"on the behalf of the Study Group on Cardiovascular Risk Biomarkers of the Italian Society of Clinical Biochemistry (SIBioC)","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B68","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1373\/clinchem.2012.192054","article-title":"Longitudinal studies of cardiac troponin I in a large cohort of healthy children","volume":"58","year":"2012","journal-title":"Clin Chem."},{"key":"key\n\t\t\t\t20170725102426_sux027-B69","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cca.2016.04.029","article-title":"Plasma cardiac troponin I concentrations in healthy neonates, children and adolescents measured with a high sensitive immunoassay method: high sensitive troponin I in pediatric age","volume":"458","year":"2016","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20170725102426_sux027-B70","first-page":"549","article-title":"Isoforms of troponin during regeneration of chicken skeletal muscle fibers after cold injury","volume":"236","year":"1984","journal-title":"Cell Tissue Res"},{"key":"key\n\t\t\t\t20170725102426_sux027-B71","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1242\/dev.110.2.547","article-title":"Cardiac troponin T indeveloping, regenerating and denervated rat skeletal muscle","volume":"110","year":"1990","journal-title":"Development"},{"key":"key\n\t\t\t\t20170725102426_sux027-B72","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/clinchem\/43.3.476","article-title":"Cardiac troponin T composition in normal and regenerating human skeletal muscle","volume":"43","year":"1997","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20170725102426_sux027-B73","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/clinchem\/45.12.2129","article-title":"RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle","volume":"45","year":"1999","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20170725102426_sux027-B74","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jacc.2011.08.026","article-title":"Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T","volume":"58","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key\n\t\t\t\t20170725102426_sux027-B75","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2014.03.027","article-title":"Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction","volume":"63","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.103.3.369","article-title":"Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes","volume":"103","year":"2001","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102426_sux027-B77","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0002-9149(99)00391-4","article-title":"Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure","volume":"84","year":"1999","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B78","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ahj.2003.10.014","article-title":"Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis","volume":"147","year":"2004","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170725102426_sux027-B79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.amjcard.2007.07.066","article-title":"Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE","volume":"101","author":"ADHERE Scientific Advisory Committee and Investigators","year":"2008","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B80","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa0706824","article-title":"Cardiac troponin and outcome in acute heart failure","volume":"358","author":"ADHERE Investigators","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B81","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ejheart.2008.06.009","article-title":"Clinical significance of cardiac troponins I and T in acute heart failure","volume":"10","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B82","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1161\/01.CIR.96.9.2953","article-title":"Circulating cardiac troponin I in severecongestive heart failure","volume":"96","year":"1997","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102426_sux027-B83","first-page":"394","article-title":"Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure","volume":"166","year":"2011","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B84","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehs191","article-title":"Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section","volume":"33","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170725102426_sux027-B85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-5-15","article-title":"Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease","volume":"5","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"key\n\t\t\t\t20170725102426_sux027-B86","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2014.09.006","article-title":"Markers of fibrosis, inflammation, and remodelling pathways in heart failure","volume":"443","year":"2015","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20170725102426_sux027-B87","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2217\/bmm.15.121","article-title":"Using the galectin-3 test to predict mortality in heart failure patients: a systematic review and meta-analysis","volume":"10","year":"2016","journal-title":"Biomark Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B88","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijcard.2014.12.137","article-title":"Prognostic value of serum galectin-3 in patients with heart failure: a meta-analysis","volume":"182","year":"2015","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B89","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4103\/0366-6999.177000","article-title":"Diagnostic value of Soluble Suppression of Tumorigenicity-2 for heart failure","volume":"129","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"key\n\t\t\t\t20170725102426_sux027-B90","first-page":"748","article-title":"Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice","volume":"46","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"key\n\t\t\t\t20170725102426_sux027-B91","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association","volume":"119","author":"American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102426_sux027-B92","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/CIRCULATIONAHA.109.912568","article-title":"Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction","volume":"123","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170725102426_sux027-B93","article-title":"Using biomarkers to guide heart failure","year":"2017","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20170725102426_sux027-B94","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchf.2013.10.005","article-title":"Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure","volume":"2","year":"2014","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B95","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cca.2015.03.033","article-title":"Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases","volume":"445","year":"2015","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20170725102426_sux027-B96","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ejhf.331","article-title":"Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study","volume":"17","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B97","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cardfail.2011.09.012","article-title":"Long-term prognostic value of CA 125 serum levels in mild to moderate heart failure patients","volume":"18","year":"2012","journal-title":"J Card Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B98","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2459\/JCM.0000000000000051","article-title":"Insights into the clinical implications of carbohydrate antigen 125 as a biomarker of heart failure: a meta-analysis and systematic review of published studies","volume":"15","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"key\n\t\t\t\t20170725102426_sux027-B99","doi-asserted-by":"crossref","first-page":"e0122360","DOI":"10.1371\/journal.pone.0122360","article-title":"Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170725102426_sux027-B100","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/eurjhf\/hfp206","article-title":"The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial","volume":"12","author":"GISSI-HF Investigators","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B101","first-page":"137","article-title":"Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department","volume":"4","journal-title":"Eur Heart J Acute Cardiovasc Care 2015"},{"key":"key\n\t\t\t\t20170725102426_sux027-B102","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cardfail.2012.01.019","article-title":"Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses","volume":"18","year":"2012","journal-title":"J Card Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B103","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.hlc.2014.10.008","article-title":"Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction","volume":"24","year":"2015","journal-title":"Heart Lung Circ"},{"key":"key\n\t\t\t\t20170725102426_sux027-B104","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/eurjhf\/hft116","article-title":"Mid-region pro-adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long-term mortality in stable outpatients with heart failure","volume":"15","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2014.11.048","article-title":"Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients","volume":"65","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B106","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.jacc.2015.09.061","article-title":"Systems Genomics Identifies a Key Role for Hypocretin\/Orexin Receptor-2 in Human Heart Failure","volume":"66","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B107","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.jacc.2015.09.085","article-title":"Eating away at heart failure","volume":"66","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170725102426_sux027-B108","article-title":"Orexin: a Missing Link Between Sleep Disorders and Heart Failure?","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"key\n\t\t\t\t20170725102426_sux027-B109","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jchf.2014.04.008","article-title":"Risk prediction in patients with heart failure","volume":"2","year":"2014","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t20170725102426_sux027-B110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jchf.2014.04.006","article-title":"Factors in\ufb02uencing the predictive power of models for predicting mortality and\/or heart-failure hospitalization in patients with heart failure","volume":"2","year":"2014","journal-title":"JACC Heart Fail"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/19\/suppl_D\/D102\/19286286\/sux027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T05:06:46Z","timestamp":1658984806000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-lookup\/doi\/10.1093\/eurheartj\/sux027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":110,"journal-issue":{"issue":"suppl_D","published-online":{"date-parts":[[2017,5,2]]},"published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/sux027","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}